FDA approves Vimizim to treat rare congenital enzyme disorder

For Immediate Release : Feb. 14, 2014 Media Inquiries : Andrea Fischer, 301-796-0393, andrea.fischer@fda.hhs.gov Consumer Inquiries : 888-INFO-FDA The U.S. Food and Drug Administration today approved Vimizim , the first FDA-approved treatment for Mucopolysaccharidosis Type IVA .

http://ift.tt/1jFIX1N